BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 17, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Clolar clofarabine regulatory update

FDA's Oncologic Drugs Advisory Committee (ODAC) will meet Sept. 1 to discuss an sNDA from Genzyme for Clolar clofarabine to treat acute myeloid leukemia (AML)...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >